InvestorsHub Logo
Followers 41
Posts 3508
Boards Moderated 2
Alias Born 09/20/2007

Re: vanegray post# 2624

Wednesday, 06/08/2022 10:07:57 AM

Wednesday, June 08, 2022 10:07:57 AM

Post# of 3095
In the press release from JAN One:

https://www.otcmarkets.com/stock/JAN/news/story?e&id=2228510

NEWS
JanOne Sells GeoTraq to SPYR Technologies in a $13.5 Million Transaction

Sale of GeoTraq allows JanOne to focus on core business strategy

LAS VEGAS, May 31, 2022 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), announced today that it has sold substantially all of the assets, and none of the liabilities, of GeoTraq Inc. ("GeoTraq"), its wholly-owned subsidiary, to SPYR Technologies Inc. ("SPYR").

"We believe this transaction further allows us to focus on our main business," said Tony Isaac CEO of JanOne. "Right now, our priority is the development of drugs with non-addictive, pain-relieving properties, specifically JAN101 (formerly known as TV1001SR), which is a potential treatment for peripheral artery disease (PAD). This sale of our subsidiary will help us continue to fund the necessary clinical trials for JAN101."

Pursuant to the Asset Purchase Agreement, the aggregate purchase price for GeoTraq was $13.5 million, payable in cash and shares of SPYR's common stock. At closing, SPYR issued to JanOne 30,000,000 shares of its common stock and delivered to JanOne a five-year Promissory Note in the initial principal amount of $12.6 million. The Promissory Note bears simple interest at the rate of 8% per annum and provides quarterly interest payments in arrears, which may be prepaid at any time without penalty.

Watch for opportunities with those you trust.